KLOW is a Curo research blend built around four peptides: GHK-Cu, BPC-157, TB-500, and KPV. This variant is weighted toward GHK-Cu, with a 50% GHK-Cu base and 10% each of BPC-157, TB-500, and KPV, giving the blend a research profile centered on repair, regeneration, extracellular-matrix signaling, and inflammatory-response models.
Research interest comes from the component peptides. GHK-Cu is studied for copper-peptide signaling, collagen, elastin, and extracellular-matrix remodeling. BPC-157 is studied in soft-tissue, tendon, ligament, and gut-lining repair models. TB-500 is studied around thymosin beta-4 pathways, cell migration, and tissue remodeling. KPV is studied in inflammatory signaling, epithelial barrier, and gut-focused research models.
The research base is best viewed at the component level unless direct KLOW-specific studies become available, with claims tied to the individual peptides and their documented research areas.